Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.61 +0.05 (+2.89%)
As of: Oct 2, 2026 · 10:20 AM EDT

Cardiol Therapeutics (CRDL) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Cardiol Therapeutics' Depreciation & Amortization (CF) was $8,347 in Q2 2026, down 54.6% from $18,382 a year earlier and down 57.1% from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cardiol Therapeutics' Depreciation & Amortization (CF) was $65,017 through Jun 30, 2026, down 31.3% year-over-year; for FY2025, it came in at $72,991, down 38.6% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -7.6% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $118,877 in FY2024 (-1.3%), $120,398 in FY2023 (+20.6%), $99,797 in FY2022 (-8.0%) and $108,504 in FY2021 (+0.2%).
  • The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) in data going back to Q4 2020.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in two of the last eight quarters, with an average decline of 26.9%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2023 (growth of 27.7%); the worst was Q2 2026 (a decline of 54.6%).
  • Per Business Quant data, CRDL's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $19,476 (Q1 2026), $18,627 (Q4 2025) and $18,566 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Cardiol Therapeutics 166.43 Mn 166.43 Mn - 8,346.90
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8,346.90
Mar 31, 2026 19,476.35
Dec 31, 2025 18,627.03
Sep 30, 2025 18,566.25
Jun 30, 2025 18,382.02
Mar 31, 2025 17,413.16
Dec 31, 2024 34,713.67
Sep 30, 2024 24,157.04
Jun 30, 2024 29,828.34
Mar 31, 2024 30,064.49
Dec 31, 2023 33,531.55
Sep 30, 2023 32,658.33
Jun 30, 2023 27,831.36
Mar 31, 2023 27,438.30
Dec 31, 2022 27,201.28
Sep 30, 2022 25,581.72
Jun 30, 2022 26,283.26
Mar 31, 2022 25,665.06
Dec 31, 2021 27,353.43
Sep 30, 2021 27,390.44
API Access

Cardiol Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRDL&period=max&api_key=YOUR_API_KEY